Companies - March 20, 2015
Zealand Pharma Reorganizes
Denmark’s Zealand Pharma has announced changes to its company’s organization and management structures. The research and development organization has been split into two parts, each with direct representation in management. In addition, investor relations & communications also will be represented directly at management level. The reorganization eliminates one management level to help streamline operations and […]
Uncategorized - March 19, 2015
BioInvent Focusing on Pediatric Cancer
Biotech company BioInvent plans to start clinical development of TB-403 for the treatment of pediatric cancer along with the Belgian biopharmabolaget Thrombogenics. A phase II/IIa program with TB-403 in patients with medulloblastoma is scheduled to start during the second half of the year 2015, BioInvent writes in a press release. BioInvent contributes half of the […]
Collaboration - March 19, 2015
U.S. Company Comes to Karolinska
The American research company Modern Therapeutics has moved into an operations base in the Karolinska Institutet Science Park, Kisp, in Flemingsberg. This will give the the researchers closer contact with the scientists at Karolinska Institutet and Karolinska University Hospital. “We will start with test ideas preclinically together with researchers at Karolinska Institutet first. Then we […]
Acquisition - March 19, 2015
Recipharm, Adroit Form Partnership
Recipharm AB and Adroit Science AB have formed a strategic partnership. The companies plan to combine their expertise in formulation development, API development, chemical analysis and other areas to reduce time and cost of development while improving quality. “I very much look forward to cooperation,” says Carl-Johan Lever, executive vice president, development & technology at […]
Uncategorized - March 18, 2015
New Findings Could Help Hemophiliacs
An international research project has shown evidence that exposing embryos to medication to control bleeding from hemophilia reduces the chance of the immune system developing resistance to it later. “As a result, the immune system will ‘think’ later in life that the medicine is part of the body’s innate functionality and so it will continue […]
Uncategorized - March 17, 2015
Scientists Take Aim at HIV
A team of scientists from Denmark, America and Germany is hoping to wipe out the HIV virus by combining two types of medicine in a “super cocktail” that is extremely toxic to the resilient HIV virus. “It’s a very important step on the way to finding a cure for HIV,” says project leader Ole Søgaard, […]
